搜尋結果
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
CNBC· 13 小時前Eli Lilly on Friday said it is investing another $5.3 billion in a manufacturing plant in ...
Many Quit Weight-Loss Drugs Too Early for Benefits, Insurer Says
Bloomberg· 4 日前Nearly 60% of Americans who started taking weight-loss drugs between 2014 and 2023 didn’t ...
Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
Reuters· 11 小時前, opens new tab said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana ...
Lilly to Invest $5.3 Billion for Weight-Loss Drug Supply
Bloomberg· 12 小時前Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg ...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 4 日前Have a confidential tip for our reporters? China gave the greenlight to Eli Lilly & Co.’s ...
Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy
Forbes· 5 日前Shares of telehealth company Hims & Hers Health closed at a three-year high Monday after the ...
Nvidia's split of soaring stock could boost retail investor appeal, Dow chances
Reuters· 17 小時前, opens new tab plan to split its stock after the stunning rise in the chipmaker's share ...
This DoubleLine bond fund is beating the market. Here's what it's buying
CNBC· 1 日前A bond fund run by two of the top names at DoubleLine is outpacing the broader market by being ...
The Top 10 S&P 500 Stocks By Weight—A Boon Or Bane?
Forbes· 3 日前The S&P 500 index closed Tuesday’s trade at 5,321.41, setting a new all-time high, above the ...
Australia to Ban Copycats of Ozempic Weight Loss Medication
Bloomberg· 3 日前Australia will ban pharmacies from creating replicas of popular weight loss drugs like Ozempic, ...